Friday Is an Important Moment for CBD Investors

I’m sure it was a surprising arrest for the onlookers — after all, it’s not every day you see a 69-year-old grandmother being arrested at Disney World.

But that’s exactly what happened last month when Hester Burkhalter was arrested at “The Happiest Place On Earth”.

InvestorPlace – Stock Market News, Stock Advice & Trading Tips” data-reactid=”14″>InvestorPlace – Stock Market News, Stock Advice & Trading Tips

And why did this happen?

Security found a vial of CBD oil in her purse for arthritis. She even had a doctor’s note.

Last year, it was a different grandmother who was arrested. 71-year-old Lena Bartula was arrested at the Dallas airport for possession of a vial of CBD oil she uses to treat her sciatica pain. Not only did she miss her flight, she spent 22 hours in jail.

Then there was 31-year-old Robert Faulkner. He was arrested in Ohio after police found a small vial of CBD oil he uses to treat his anxiety during a DUI arrest.

At the time of arrest, all three individuals were charged with felonies.

What’s behind these incidents is confusion surrounding CBD, marijuana, and the exploding popularity of CBD-infused products of all kinds.

Given this confusion, on Friday, the U.S. Food and Drug Administration is finally holding its first public hearing on the topic of how to regulate CBD-infused products.

CBD is what’s called a non-psychoactive compound found in both the cannabis and hemp plants. That’s a fancy way of saying CBD will not get you “high.”

It’s actually been used by wellness and medical professionals for years as an alternative to traditional pharmaceuticals to treat everything from anxiety and depression to chronic pain to the reduction of inflammation to childhood epilepsy. If it were a drug, we would call it a wonder drug.

Investment Opportunities. While a great many other analysts are just now jumping on the marijuana bandwagon, Matt has been a leader in the space since 2014.

But if CBD is so beneficial — even a “wonder drug” as Matt calls it — why the arrests?

It boils down to a lack of clarity from our legislators.

You see, CBD made from hemp is now legal thanks to the 2018 Farm Bill. However, CBD made from marijuana is still illegal. That’s because marijuana remains a controlled substance.

This “legal/illegal” issue has led to gray area and confusion when it comes to CBD-infused products. Is it CBD from hemp, or from marijuana? Even if it’s from hemp, does it really contain zero THC?

For example, Hester Burkhalter’s CBD oil tested positive for THC, despite the fact that the bottle reportedly claimed it contained zero milligrams of THC.

Beyond the arrests of grandmothers, the lack of formal guidance from the FDA has led state and local officials around the nation to shut down the sale of certain CBD-infused foods and beverages for fear of violating federal law.

For instance, in February, the New York City Department of Health started cracking down on restaurants selling CBD-infused foods, issuing warnings to stop such sales. Starting this coming October, they’ll officially begin issuing fines — even potentially lowering a restaurant’s health letter grade.

On the other hand, retailers are taking more risks with CBD-infused topicals, like lotions and creams. For example, Walgreens, Rite Aid, and CVS have all announced they’re selling CBD-infused topicals. The idea seems to be there’s less danger of complications if the CBD is applied externally versus ingested.

But given the public demand for CBD-infused foods and beverages, politicians and the public have been pushing the FDA for more formal guidance. The hearing on Friday is the FDA’s step toward this guidance.

Over this past Memorial Day weekend, The Transportation Security Administration (TSA) updated its cannabis policy, changing the medical marijuana section of its “What Can I Bring?” webpage from reading “no” to “yes” (with “special instructions”).

The agency has clarified that hemp-derived CBD products can now be taken on planes under certain circumstances. Previously, TSA didn’t make a distinction between marijuana and hemp-based CBD, and warned that cannabis products cannot be taken as carry-on items.

Last year, retail sales of CBD products in the U.S. were estimated between $600 million and $2 billion, according to the investment research firm Cowen. By 2025, the group conservatively forecasts sales to reach $16 billion, with health and wellness products leading the way.

Investment Opportunities subscribers. It makes and distributes supplements and skincare products in the hemp-CBD market. Since Matt’s recommendation on early December, the stock is up 138%.

On the flip, if CBD’s popularity is anchored in real, substantiated medical benefits, then what we’re seeing may not be a bubble at all, but rather the beginning of a multi-year bull market for a sector that’s capable of generating major wealth.

In writing this issue, I’ve come across many headlines pointing toward CBD’s health benefits. For example:

Looking for the final word on CBD’s health benefits, I went to the Harvard Medical School website, a source which I believe the majority of us would consider an authority.

From its website:

CBD is commonly used to address anxiety, and for patients who suffer through the misery of insomnia, studies suggest that CBD may help with both falling asleep and staying asleep.

So, the literature from Harvard appears to be supportive. But there was one final aspect of Harvard’s write-up which I found ironic …

That brings us full circle to Hester Burkhalter’s unregulated bottle of CBD that actually contained THC, the FDA, and its public hearing on Friday.

Let’s hope that the FDA finally provides the regulation and clarification needed to enable more scientific study, avoid pointless arrests, and better outline appropriate uses of the CBD.

But similar to marijuana legalization, the time to be invested is before all the gray area is removed. That’s because when that clarity comes, it will likely unleash an avalanche of new investment dollars which could be a massive tailwind, driving your previously-established position higher.

Cannabis Cash Calendar investment this Friday. His April recommendation is currently up 65%. You can click here to learn more.

Have a good evening,

Jeff Remsburg

Compare Brokers ” data-reactid=”64″>Compare Brokers

Friday Is an Important Moment for CBD Investors appeared first on InvestorPlace.” data-reactid=”65″>The post Friday Is an Important Moment for CBD Investors appeared first on InvestorPlace.

Author: CSN